Stories

The Coalition of Asia Pacific Tobacco Harm Reduction Advocates supports WHO concerns about youth marketing of nicotine pouches but warns against overly restrictive policies that could hinder adult access to safer alternatives. CAPHRA emphasizes the importance of balancing youth protection with adult harm reduction. They advocate for cracking down on youth-targeted promotion, implementing strict age controls, and maintaining regulated adult access while upholding strong product standards. Emphasizing the dangers of combustible tobacco, CAPHRA stresses the need for a risk-proportionate approach to regulation. The group urges WHO to focus on evidence-based guidance that prioritizes reducing harm without limiting adult choices.

Understanding nicotine-related risk requires distinguishing between the harms caused by nicotine itself and those caused primarily by tobacco combustion. Public debate and media coverage often present nicotine as uniformly harmful, despite substantial differences in risk profiles between combustible and non-combustible products. Researchers and harm reduction advocates increasingly argue that inaccurate risk perception may contribute to persistent smoking by discouraging smokers from switching to lower-risk alternatives. Improving public understanding of relative risk remains a central challenge in evidence-based tobacco harm reduction and public health communication.

Understanding nicotine-related risk requires distinguishing between the harms caused by nicotine itself and those caused primarily by tobacco combustion. Public debate and media coverage often present nicotine as uniformly harmful, despite substantial differences in risk profiles between combustible and non-combustible products. Researchers and harm reduction advocates increasingly argue that inaccurate risk perception may contribute to persistent smoking by discouraging smokers from switching to lower-risk alternatives. Improving public understanding of relative risk remains a central challenge in evidence-based tobacco harm reduction and public health communication.

Spain’s proposed restrictions on vaping and other reduced-risk nicotine products have intensified criticism from harm reduction advocates and public health commentators. Critics argue that treating non-combustible nicotine products in the same way as cigarettes risks obscuring important differences in toxicological exposure and relative risk. Concerns have also been raised that increasingly restrictive regulation may discourage smokers from switching away from combustible tobacco, potentially slowing declines in smoking prevalence. The debate reflects wider tensions across Europe between precautionary nicotine regulation, smoking cessation goals, and evidence-based approaches to tobacco harm reduction.

Sweden’s experience with low smoking prevalence continues to play a central role in debates surrounding tobacco harm reduction and nicotine regulation. Critics argue that current international policy discussions often overlook epidemiological evidence showing significant reductions in smoking-related disease in populations with widespread use of non-combustible nicotine products. The debate highlights growing tensions between precautionary approaches to nicotine regulation and harm reduction models focused on reducing exposure to combustion-related toxicants. Questions remain over whether public health policy should prioritize nicotine abstinence alone or broader strategies aimed at accelerating the decline of cigarette smoking and smoking-related mortality.

The WHO’s first global report on nicotine pouches has intensified debate around the role of non-combustible nicotine products in tobacco harm reduction policy. While the report raises concerns related to youth uptake, product regulation, and long-term health uncertainties, critics argue that the discussion gives insufficient attention to the relative risk differences between nicotine pouches and combustible cigarettes. Researchers and harm reduction advocates continue to emphasize the importance of distinguishing between nicotine use and the harms caused primarily by tobacco combustion. The debate reflects broader disagreements over how public health institutions should balance precautionary regulation with evidence-based approaches to reducing smoking-related disease and mortality.

Growing criticism of modern tobacco control increasingly centres on concerns that public health policy has shifted away from smoking cessation and toward nicotine prohibition. Critics argue that ideological approaches, misinformation, and the dismissal of harm reduction strategies may be undermining progress in reducing smoking-related disease. The debate also highlights tensions between public health objectives, consumer autonomy, and the role of scientific evidence in shaping regulation of safer nicotine products. As smoking rates continue to decline in many countries, questions are emerging over whether current tobacco control frameworks are adapting effectively to new technologies and evolving patterns of nicotine use.

New research on e-cigarettes continues to fuel debate around the balance between toxicological risk and tobacco harm reduction. While some studies identify potentially harmful compounds generated during heating and flavouring processes, researchers also note that exposure levels in non-combustible nicotine products remain substantially lower than those associated with cigarette smoke. The growing body of evidence highlights the importance of distinguishing between absolute risk and relative risk when evaluating nicotine products in public health policy. Scientists increasingly argue that toxicological findings should be interpreted within the broader context of smoking-related disease prevention and harm reduction strategies.

Expert reactions to the WHO report on nicotine pouches reflect ongoing divisions within public health and tobacco control research. While concerns continue to focus on youth uptake, nicotine dependence, and product marketing practices, several researchers argue that risk communication should also acknowledge the substantially lower harm profile of non-combustible nicotine products compared with cigarettes. Critics warn that presenting all nicotine products as equally harmful may contribute to growing public misperceptions and discourage smokers from switching away from combustible tobacco. The debate highlights broader tensions between precautionary regulation, harm reduction principles, and the role of scientific evidence in shaping public health policy.

Belgium's ban on flavoured vapes and eLiquids, effective September 2028, is criticized by experts who fear it will hinder smoking cessation efforts. Supporters argue that flavours help adult smokers quit tobacco. The decision, labeled as scaremongering by the World Vapers' Alliance, was condemned for pushing vapers back to smoking or the black market. Evidence shows flavoured e-cigarettes aid smoking cessation, with bans potentially leading to relapses. Critics urge governments to learn from successful smoke-free models in other countries and focus on restricting youth access instead of impeding adult cessation methods. This ban risks exacerbating public health issues and undermining harm reduction efforts.